GS
IDXX icon

GTS Securities’s Idexx Laboratories IDXX Stock Holding History

GTS Securities’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$360K Sell
640
-573
-47% -$367K 0.01% 985
2025
Q4 		$821K Sell
1,213
-614
-34% -$418K 0.03% 524
2025
Q3 		$1.17M Buy
+1,827
New +$1.11M 0.04% 348
2025
Q2 		– Sell
-837
Closed -$351K – 1414
2025
Q1 		$351K Buy
837
+229
+38% +$99.4K 0.02% 873
2024
Q4 		$251K Sell
608
-470
-44% -$206K 0.01% 986
2024
Q3 		$545K Buy
1,078
+651
+152% +$316K ﹤0.01% 2741
2024
Q2 		$208K Buy
+427
New +$214K ﹤0.01% 3418
2024
Q1 		– Sell
-626
Closed -$347K – 4127
2023
Q4 		$347K Sell
626
-193
-24% -$90.6K ﹤0.01% 3088
2023
Q3 		$358K Buy
+819
New +$408K ﹤0.01% 2910

Other funds holding IDXX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

GTS Securities's IDXX Position: Q1 2026 in Review

GTS Securities reduced its Idexx Laboratories (IDXX) stake by 47% in Q1 2026, selling an estimated $367K and leaving 640 shares worth $360K. The position accounts for 0.01% of the portfolio, ranked #985.

GTS Securities first reported a position in IDXX in Q3 2023 and has held it in 9 quarters since. The position peaked at $1.17M in Q3 2025. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.

  • GTS Securities held 640 shares of Idexx Laboratories worth $360K as of Q1 2026.
  • GTS Securities sold 573 Idexx Laboratories shares in Q1 2026, an estimated $367K.
  • Idexx Laboratories made up 0.01% of GTS Securities's portfolio in Q1 2026, its #985 holding.
  • GTS Securities first reported a position in Idexx Laboratories in Q3 2023 and has held it in 9 quarters since.
  • GTS Securities's Idexx Laboratories position peaked at $1.17M in Q3 2025.
  • 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.

Based on GTS Securities's 13F filing for Q1 2026, filed 15 May 2026.